Full Press Release Details
IDEAYA Announces IDE397 IND Clearance by U S FDA to Initiate Phase 1 and Appointment of Matthew Maurer M D as Vice President Head of Clinical Oncology and Medical Affairs.
IDYA
IDEAYA Announces IDE397 IND Clearance by U S FDA to Initiate Phase 1 and Appointment of Matthew Maurer M D as Vice President Head of Clinical Oncology and Medical Affairs
Key Takeaway: IDEAYA Announces IDE397 IND Clearance by U S FDA to Initiate Phase 1 and Appointment of Matthew Maurer M D as Vice President Head of Clinical Oncology and Medical Affairs